Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1998 6
1999 2
2000 2
2001 5
2002 1
2003 6
2004 5
2005 2
2006 1
2007 2
2008 2
2009 3
2010 7
2011 2
2012 9
2013 11
2014 10
2015 8
2016 7
2017 8
2018 5
2019 4
2020 10
2021 10
2022 7
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Toward precision medicine in myotonic syndromes.
De Bellis M, Camerino DC, Desaphy JF. De Bellis M, et al. Among authors: desaphy jf. Oncotarget. 2017 Feb 28;8(9):14279-14280. doi: 10.18632/oncotarget.15263. Oncotarget. 2017. PMID: 28199958 Free PMC article. No abstract available.
Target Mutation-Driven Drug Discovery.
Altamura C, Conte D, Carratù MR, Desaphy JF. Altamura C, et al. Among authors: desaphy jf. Curr Med Chem. 2022 Aug 15;29(31):5156-5158. doi: 10.2174/1389450123666220418111200. Curr Med Chem. 2022. PMID: 35440295 No abstract available.
Ion Channel Involvement in Tumor Drug Resistance.
Altamura C, Gavazzo P, Pusch M, Desaphy JF. Altamura C, et al. Among authors: desaphy jf. J Pers Med. 2022 Feb 3;12(2):210. doi: 10.3390/jpm12020210. J Pers Med. 2022. PMID: 35207698 Free PMC article. Review.
Drug repurposing in skeletal muscle ion channelopathies.
Altamura C, Saltarella I, Campanale C, Laghetti P, Desaphy JF. Altamura C, et al. Among authors: desaphy jf. Curr Opin Pharmacol. 2023 Feb;68:102329. doi: 10.1016/j.coph.2022.102329. Epub 2022 Dec 10. Curr Opin Pharmacol. 2023. PMID: 36512979 Review.
Ion channel pharmacology.
Camerino DC, Tricarico D, Desaphy JF. Camerino DC, et al. Among authors: desaphy jf. Neurotherapeutics. 2007 Apr;4(2):184-98. doi: 10.1016/j.nurt.2007.01.013. Neurotherapeutics. 2007. PMID: 17395128 Review.
Anti-Angiogenic Activity of Drugs in Multiple Myeloma.
Saltarella I, Altamura C, Campanale C, Laghetti P, Vacca A, Frassanito MA, Desaphy JF. Saltarella I, et al. Among authors: desaphy jf. Cancers (Basel). 2023 Mar 27;15(7):1990. doi: 10.3390/cancers15071990. Cancers (Basel). 2023. PMID: 37046651 Free PMC article. Review.
Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.
Imbrici P, Altamura C, Camerino GM, Mangiatordi GF, Conte E, Maggi L, Brugnoni R, Musaraj K, Caloiero R, Alberga D, Marsano RM, Ricci G, Siciliano G, Nicolotti O, Mora M, Bernasconi P, Desaphy JF, Mantegazza R, Camerino DC. Imbrici P, et al. Among authors: desaphy jf. FASEB J. 2016 Oct;30(10):3285-3295. doi: 10.1096/fj.201500079R. Epub 2016 Jun 20. FASEB J. 2016. PMID: 27324117 Free PMC article.
129 results